PUBLISHER: TechNavio | PRODUCT CODE: 1581880
PUBLISHER: TechNavio | PRODUCT CODE: 1581880
Neurovascular Devices Market 2024-2028
The neurovascular devices market is forecasted to grow by USD 777.4 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the neurovascular devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of favorable reimbursement coverage, outsourcing neurovascular devices research to CROs, and increasing incidence of aneurysms.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 4.23% |
CAGR | 4.5% |
Incremental Value | $777.4 mn |
Technavio's neurovascular devices market is segmented as below:
By Product
By Geographical Landscape
This study identifies the market expansion in emerging economies as one of the prime reasons driving the neurovascular devices market growth during the next few years. Also, new technological advancements and growing number of clinical trials will lead to sizable demand in the market.
The report on the neurovascular devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurovascular devices market vendors that include Acandis GmbH, Asahi Intecc Co. Ltd., BALT Group, Cerus Endovascular Inc., Evasc Medical Systems Corp., Imperative Care Inc., Integer Holdings Corp., Integra Lifesciences Corp., Johnson and Johnson Services Inc., Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., Medtronic PLC, MicroPort Scientific Corp., Penumbra Inc., Perflow Medical Ltd., phenox GmbH, Rapid Medical Ltd., SENSOME, Stryker Corp., and Terumo Corp.. Also, the neurovascular devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: